FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18523811000001103: Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Mar 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63623801000001118 Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
63623901000001112 Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Is a Zolmitriptan 2.5mg orodispersible tablets 6 tablet true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Has AMP Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Has specific active ingredient Zolmitriptan true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Has dispensed dose form Orodispersible tablet false Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zomig Rapimelt 2.5mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 6 tablet Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start